Sutent fails breast cancer trial
Drugmaker Pfizer has stopped a late-stage trial on the drug Sutent because it was not proving effective for patients with advanced breast cancer.
More... |
All times are GMT -7. The time now is 04:42 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021